© 2021 MJH Life Sciences and HCPLive - Clinical news for connected physicians. All rights reserved.
© 2021 MJH Life Sciences™ and HCPLive - Clinical news for connected physicians. All rights reserved.
August 03, 2021
The cumulative time to curative treatment failure rates of patients who received DAA were 93.6% and 73.2% at 1 and 3 years, respectively.
Improving health literacy among these individuals may have a significant and positive impact on the transition from pediatric to adult care.
Kelly Chin, MD discusses the recent FDA approval of selexipag IV and breakthroughs in the cardiovascular care space.
Researchers call for greater research on the relationship between PTSD and autoimmune diseases in Medicaid patients after finding a troubling association.
The platform leverages optical coherence tomography and Ultreon Software.
Data show the expression levels of miR-214, BNP, NT-proBNP, and sST2 were significantly higher compared to the control group.
Higher depressive and manic (symptoms were associated with lower GAF, most strongly among the older participants.
August 02, 2021
Brett King, MD, PhD, provides an overview of JAK inhibitors and their interaction with the JAK-STAT pathway.
Italy and the Netherlands both achieved their target HBV control.